The document explores the concept of polymorphism in pharmaceuticals, defining it as the existence of a substance in multiple crystalline forms. It discusses the types of polymorphs, methods for their identification, and their implications for drug stability and bioavailability, noting the significance of both true polymorphs and pseudopolymorphs. Additionally, various analytical techniques such as X-ray diffraction and differential scanning calorimetry are described for studying polymorphic forms and their properties.